VA Pharmacy Prime Vendor Contract Exceeds $183M, McKesson Corporation Awarded
Contract Overview
Contract Amount: $183,754,817 ($183.8M)
Contractor: Mckesson Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2014-03-01
End Date: 2014-03-30
Contract Duration: 29 days
Daily Burn Rate: $6.3M/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 5
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EXPRESS REPORT PHARMACY PRIME VENDOR VA760PPVFY14MAR
Place of Performance
Location: SAN FRANCISCO, SAN FRANCISCO County, CALIFORNIA, 94104
Plain-Language Summary
Department of Veterans Affairs obligated $183.8 million to MCKESSON CORPORATION for work described as: EXPRESS REPORT PHARMACY PRIME VENDOR VA760PPVFY14MAR Key points: 1. Significant contract value of $183.75M for pharmaceutical supplies. 2. McKesson Corporation is a major player in the pharmaceutical distribution market. 3. Potential risk associated with reliance on a single large vendor for critical supplies. 4. Spending falls within the broad 'Healthcare' sector, specifically pharmaceutical manufacturing.
Value Assessment
Rating: good
The contract's pricing is based on a Firm Fixed Price (FFP) award, which provides cost certainty. Benchmarking against similar large-scale pharmaceutical distribution contracts would be necessary for a definitive assessment, but the scale suggests competitive pricing was sought.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating a robust price discovery process. This method aims to ensure the government receives the best value by allowing all eligible sources to compete.
Taxpayer Impact: The full and open competition likely resulted in favorable pricing for taxpayers by leveraging market competition for essential pharmaceutical supplies.
Public Impact
Ensures a consistent supply of pharmaceuticals to Veterans Affairs facilities. Supports the healthcare needs of a significant veteran population. Impacts the pharmaceutical supply chain and distribution network. Potential for cost savings through competitive bidding.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Contract duration is short (29 days), suggesting it might be a bridge or specific delivery order.
- Lack of detailed performance metrics in the provided data.
- Potential for price fluctuations if not managed tightly post-award.
Positive Signals
- Awarded under full and open competition.
- Firm Fixed Price contract type offers cost predictability.
- Significant contract value indicates a large-scale, important procurement.
Sector Analysis
This contract falls under the Healthcare sector, specifically focusing on pharmaceutical preparation manufacturing and distribution. Spending benchmarks in this area are typically high due to the critical nature and cost of medical supplies.
Small Business Impact
The data does not indicate any specific set-asides for small businesses. Given the scale and nature of the contract, it is likely awarded to a large prime vendor, with subcontracting opportunities for small businesses potentially existing but not explicitly detailed here.
Oversight & Accountability
The Department of Veterans Affairs is responsible for oversight. The 'Delivery Order' nature suggests it's part of a larger contract vehicle, implying existing oversight mechanisms are in place. Further review of performance reports would be needed.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Vendor Lock-in Potential
- Supply Chain Vulnerability
- Price Escalation Risk
- Dependence on a Single Large Supplier
Tags
pharmaceutical-preparation-manufacturing, department-of-veterans-affairs, ca, delivery-order, 100m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $183.8 million to MCKESSON CORPORATION. EXPRESS REPORT PHARMACY PRIME VENDOR VA760PPVFY14MAR
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $183.8 million.
What is the period of performance?
Start: 2014-03-01. End: 2014-03-30.
What is the historical pricing trend for this vendor under similar contracts?
Analyzing historical pricing data for McKesson Corporation under comparable Pharmacy Prime Vendor contracts would reveal if the current award reflects competitive trends or potential escalations. This historical context is crucial for assessing long-term value and identifying any deviations from expected price points over time.
What are the specific performance metrics and service level agreements tied to this contract?
Understanding the contract's performance metrics, such as delivery timeliness, fill rates, and product quality standards, is essential for evaluating its effectiveness. Robust SLAs ensure that the VA receives not only competitively priced pharmaceuticals but also reliable and high-quality services critical for patient care.
How does the VA manage potential supply chain disruptions with a single large vendor?
The VA likely employs risk mitigation strategies, such as contingency planning, maintaining safety stock levels, and potentially diversifying suppliers for critical items, to address risks associated with relying on a single large vendor like McKesson. Continuous monitoring of the supply chain is key.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 5
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: ONE POST ST, SAN FRANCISCO, CA, 94104
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $183,754,817
Exercised Options: $183,754,817
Current Obligation: $183,754,817
Contract Characteristics
Commercial Item: COMMERCIAL ITEM
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: VA797P12D0001
IDV Type: IDC
Timeline
Start Date: 2014-03-01
Current End Date: 2014-03-30
Potential End Date: 2014-03-30 00:00:00
Last Modified: 2019-08-20
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)